Ngm Biopharmaceuticals Inc (NGM) Return on Investment ROI from the fourth quarter of 2023 to fourth quarter of 2022 and for the year 2023, average high and low, overall ranking from Dec 31 2023 to Dec 31 2022 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Ngm Biopharmaceuticals Inc   (NASDAQ: NGM)


Ngm Biopharmaceuticals Inc's ROI from its fourth quarter of 2023 to the fourth quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Ngm Biopharmaceuticals Inc's ROI in the fourth quarter of 2023?
Ngm Biopharmaceuticals Inc recorded a cumulative net loss of $-142 million during 12 months ending in the fourth quarter of 2023, resulting in a negative return on investment (ROI) of -77.84%.

Within the Healthcare sector 679 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2023 from 4098 to 4262.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter
Y / Y Investment Change TTM -36.76 % -31.97 % -26.68 % -23.68 % -21.96 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 149 170 192 221 260
Return On Investment (TTM) -77.84 % -71.77 % -70.68 % -66.95 % -56.24 %
NGM's Overall Ranking # 4262 # 4098 # 4288 # 1932 # 0
Seq. Investment Change TTM -13.15 % -12.24 % -9.67 % -8.15 % -6.58 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -142 -151 -170 -178 -163

NGM Company Profile >> Back to NGM Roi Comparisons >> See Annual NGM Return On Investment



Return On Investment NGM's Ranking
Within: No.
Industry # 308
Sector # 680
Overall # 4262

Return On Investment Statistics
High Average Low
-13.83 %
-40.96 %
-77.84 %
(Dec 31 2019)   (Dec 31 2023)







Financial Statements
Ngm Biopharmaceuticals Inc's IV. Quarter Investments $ 149 Millions NGM's Balance sheet
Ngm Biopharmaceuticals Inc's IV. Quarter Income $ -28 Millions Quarterly NGM's Income Statement
NGM's Income by Division See NGM's Income by Division


NGM Annual Return On Investment (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019
Total Investments in Millions 149 260 341 286 341
Y / Y Investment Growth -42.68 % -23.89 % 19.05 % -15.92 % -
Net Income in Millions -142 -163 -120 -102 -43
Y / Y Net Income Growth - - - - -
Annual Return On Investment -95.69 % -62.67 % -35.29 % -35.78 % -12.56 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
NGM's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for NGM's Competitors
Subscribers only: Roi for Ngm Biopharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for NGM's Customers

Other Ratios
NGM's Roa NGM's Inventory Turnover Ratio NGM's Growth Rates NGM's Dividend Statistics
NGM's Profitability Ratios NGM's Asset Turnover Ratio NGM's Dividend Growth
NGM's Roe NGM's Valuation Ratios NGM's Financial Strength Ratios NGM's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2023, within Healthcare Sector ROI

Date modified: 2026-09-18T13:11:05+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.